Xrhamm is the ortholog of a candidate low-penetrance breast cancer susceptibility gene product (RHAMM, HMMR gene) [23] whose over-expression in tumors is associated with poor prognosis and early age at diagnosis [23]–[25]. Here, HMMR is linked to breast carcinoma.